Back to Search
Start Over
Subcutaneous IgG in the Myositis Spectrum Disorders.
- Source :
-
Current rheumatology reviews [Curr Rheumatol Rev] 2018; Vol. 14 (3), pp. 194-199. - Publication Year :
- 2018
-
Abstract
- The efficacy of subcutaneous immunoglobulin is reported in several neurological disorders and, more recently, its use has been extended to other inflammatory diseases, such as the idiopathic inflammatory myopathies, including polymyositis and dermatomyositis. Due to the rarity of these disorders, the role of immunoglobulin, administered intravenously or subcutaneously, remains unclear and poorly investigated. We report our experience about the use of subcutaneous immunoglobulin in myositis spectrum disorders, from idiopathic inflammatory myopathies to more complex conditions, such as overlap and cancer-associated myositis or pregnancy.<br /> (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.)
- Subjects :
- Adult
Aged
Child
Drug Administration Schedule
Female
Humans
Immunoglobulin G adverse effects
Immunoglobulins, Intravenous administration & dosage
Immunologic Factors adverse effects
Infusions, Subcutaneous
Male
Middle Aged
Myositis diagnosis
Myositis immunology
Treatment Outcome
Young Adult
Immunoglobulin G administration & dosage
Immunologic Factors administration & dosage
Myositis drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1875-6360
- Volume :
- 14
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Current rheumatology reviews
- Publication Type :
- Academic Journal
- Accession number :
- 28292255
- Full Text :
- https://doi.org/10.2174/1573397113666170314120602